Chapter1

ExecutiveSummary

ExecutiveSummary1-1

Introduction1-1

MarketOverview1-1

ScopeofResearch1-2

SummaryofMajorFindings1-2

MarketGrowthandOpportunities1-2

ExamplesofanIndustryChallenge1-3

ComplexityinHandlingandAdministeringEnteral

NutritioninHomeSettings1-3

ExamplesofMarketDrivers1-3

FavorableReimbursementRegulations1-4

IncreasingHealthcareCostsDriveConsumerstoward

CommunityCare1-4

KeyMarketRestraints1-4

ReductioninHospitalStayduetoAdvancementsinMedicalSciences1-4

PreventiveMedicineDecreasingtheNeedforEN1-5

CompetitiveAnalysis1-5

ExamplesofConclusionandRecommendations1-5

Chapter2

IntroductiontotheEnteralNutritionMarket

Introduction2-1

NutritioninClinicalManagement2-1

RoleofDietinClinicalManagement2-1

DefinitionsofEnteralandTotalParenteralNutrition2-2

EnteralNutrition2-2

TotalParenteralNutrition2-3

DifferencesbetweenEnteralandParenteralNutrition2-3

EnteralNutritioninClinicalManagement2-3

RoutesofAdministrationofTubeFeeds2-3

MethodsofAdministrationofTubeFeeds2-4

EnteralNutrition—AdvantagesandDisadvantages2-4

Advantages2-4

Disadvantages2-5

ClassificationofEnteralFeedFormulae2-5

StandardFormulae2-5

SpecializedFormulae2-6

PolymericFormulae2-6

OligomericFormulae2-6

ModularFormulae2-7

IndustryStructure2-7

DistributionChannels2-7

CommunityCare2-8

Hospitals2-8

PurchasingCriteria2-8

RegulatoryandReimbursementOverview2-9

IndustryAssociations2-9

RegulatoryBodies2-9

TheAmericanSocietyforEnteralandParenteralNutrition2-9

InternationalFormulaCouncil2-9

ReimbursementOrganizations2-9

Medicare2-10

Medicaid2-11

RegulationsintheU.S.2-12

TheOrphanDrugAmendmentAct(ODA)，19832-12

TheMedicareandMedicalNutritionTherapy(MNT)ActH.R.1582andS.604，20052-12

CompanyProfiles2-13

AbbottLaboratories2-13

CorporateHeadquarters2-13

CompanyOverview2-13

CompanyHistoryandCurrentActivities2-13

FinancialResults2-14

ActivityinEnteralNutritionMarket2-14

ExamplesofIndustryActivities2-14

B.BraunMelsungenAG2-14

CorporateHeadquarters2-14

CompanyOverview2-15

CompanyHistoryandCurrentActivities2-15

FinancialResults2-15

ActivityintheEnteralNutritionMarket2-15

StandardDiets2-15

Disease-specificDiets2-16

ExamplesofIndustryActivity2-16

NovartisAG2-16

CorporateHeadquarters2-16

CompanyOverview2-16

CompanyHistoryandCurrentActivities2-17

FinancialResults2-17

ActivityintheEnteralNutritionMarket2-17

ExamplesofIndustryActivity2-17

Nestle2-18

CorporateHeadquarters2-18

CompanyOverview2-18

CompanyBackgroundandCurrentActivities2-18

FinancialResults2-19

ActivityintheEnteralNutritionMarket2-19

ExamplesofIndustryActivities2-19

NutriciaNorthAmerica2-19

CorporateHeadquarters2-19

CompanyOverview2-20

CompanyBackgroundandCurrentActivities2-20

FinancialResults2-20

ActivitiesintheEnteralNutritionMarket2-20

ExamplesofIndustryActivities2-21

MarketDynamics2-21

MergersandAcquisitions2-21

RoyalNumicoN.VAcquiredEACNutrition2-21

NovartisMedicalNutritionAcquiredSemperClinicalNutrition2-21

NovartisAcquiredMeadJohnson’sAdultMedicalNutritionBusiness2-22

AlliancesandJointVentures2-22

JointVenture:BioGaiaandNovartis2-22

JointVenture:ZevexInternationalandNutricia2-22

IndustryChallenge2-22

Challenge2-22

ComplexityinHandlingandAdministeringEnteralNutritioninHomeSettings2-23

StrategicRecommendations2-23

StrategiestoOvercomeDifficultiesinAdministeringEnteralNutritioninHomeSettings2-23

FocusonCoreAreasofBusiness2-24

EmphasisonResearchandDevelopment2-24

FocusingonValue-addedServices2-24

Chapter3

StrategicAnalysisoftheU.S.EnteralNutritionMarket

MarketOverview3-1

Introduction3-1

ScopeofResearch3-1

ResearchMethodology3-2

MarketDrivers3-2

FavorableReimbursementRegulations3-3

IncreasingHealthcareCostsDriveConsumerstowardCommunityCare3-3

CostBenefitsandEffectivenessofEnteralNutrition(EN)FavoritsUse

OverTotalParenteralNutrition(TPN)3-4

AdvancementsinEnteralFeedingDevicesAidMarketGrowth3-4

CustomizedFormulaeforSpecificDiseases3-5

IncreasingGeriatricPopulationAugmentsDemandforEnteralNutritionProducts3-5

IncreasingResearchandDevelopmentExpendituretowardsDevelopmentofEnteralNutrition3-5

MarketRestraints3-6

ReductioninHospitalStayduetoAdvancementsinMedicalScience3-7

PreventiveMedicineDecreasingtheNeedforEnteralNutrition3-7

ForecastsandTrends3-7

MarketEngineeringMeasurements3-7

UnitShipmentandRevenueForecasts3-8

PricingTrends3-10

TechnologyTrends3-11

NutritionalIngredients3-12

EnteralTubeDevices3-12

CompetitiveAnalysis3-13

CompetitiveStructure3-13

TypesofCompetitors3-14

DistributionStructure3-14

KeyEnd-UserGroups3-14

CompetitiveFactors3-14

MarketShareAnalysis3-14

Chapter4

HealthcareintheU.S.

Healthcare4-1

U.S.HealthcareSystem4-1

HealthcareOrganizations4-1

HealthcareServices4-1

HealthcareFunding4-2

PrivateHealthcare4-3

GovernmentorCharitableHealthcare4-4

CommunityCare4-4

AgingDemographics4-5

HomeEnteralNutrition(HEN)4-6

TrendsandDevelopments4-6

Chapter5

IngredientsUsedinEnteralNutrition—TrendsandOpportunities

EnteralFeedIngredients5-1

TrendsandOpportunities5-1

Carbohydrates5-2

Fiber5-2

PrebioticsandProbiotics5-2

ProteinsandAminoAcids5-3

BranchedChainAminoAcids(BCAAs)5-3

EssentialAminoAcids5-3

FattyAcids5-4

NucleicAcids5-4

Microencapsulation5-4

Biotechnology5-4

Chapter6

DatabaseofKeyIndustryParticipants

KeyIndustryParticipants6-1

ListofManufacturers6-1

Chapter7

DecisionSupportDatabase

ReferenceTables7-1

NumberofNursingHomeResidents7-1

MalePopulation65andAbove7-2

FemalePopulation65andabove7-4

IncidenceofHIV7-7

MortalityduetoCerebrovascularDiseases7-9

PrevalenceofDiabetes

Strategic Analysis of the U.S. Enteral Nutrition Markets